These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2784290)

  • 1. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins.
    Fong Y; Moldawer LL; Marano M; Wei H; Barber A; Manogue K; Tracey KJ; Kuo G; Fischman DA; Cerami A
    Am J Physiol; 1989 Mar; 256(3 Pt 2):R659-65. PubMed ID: 2784290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
    Tracey KJ; Wei H; Manogue KR; Fong Y; Hesse DG; Nguyen HT; Kuo GC; Beutler B; Cotran RS; Cerami A
    J Exp Med; 1988 Mar; 167(3):1211-27. PubMed ID: 3351436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.
    Tracey KJ; Morgello S; Koplin B; Fahey TJ; Fox J; Aledo A; Manogue KR; Cerami A
    J Clin Invest; 1990 Dec; 86(6):2014-24. PubMed ID: 2254457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle.
    Lang CH; Silvis C; Deshpande N; Nystrom G; Frost RA
    Shock; 2003 Jun; 19(6):538-46. PubMed ID: 12785009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo.
    Moldawer LL; Marano MA; Wei H; Fong Y; Silen ML; Kuo G; Manogue KR; Vlassara H; Cohen H; Cerami A
    FASEB J; 1989 Mar; 3(5):1637-43. PubMed ID: 2784116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1.
    Flores EA; Bistrian BR; Pomposelli JJ; Dinarello CA; Blackburn GL; Istfan NW
    J Clin Invest; 1989 May; 83(5):1614-22. PubMed ID: 2785120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat.
    Stovroff MC; Fraker DL; Swedenborg JA; Norton JA
    Cancer Res; 1988 Aug; 48(16):4567-72. PubMed ID: 3165053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic responses to cachectin/TNF. A brief review.
    Tracey KJ; Cerami A
    Ann N Y Acad Sci; 1990; 587():325-31. PubMed ID: 2193578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cachectin/TNF production in experimental burns and Pseudomonas infection.
    Marano MA; Moldawer LL; Fong Y; Wei H; Minei J; Yurt R; Cerami A; Lowry SF
    Arch Surg; 1988 Nov; 123(11):1383-8. PubMed ID: 3178487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional, hepatic, and metabolic effects of cachectin/tumor necrosis factor in rats receiving total parenteral nutrition.
    Matsui J; Cameron RG; Kurian R; Kuo GC; Jeejeebhoy KN
    Gastroenterology; 1993 Jan; 104(1):235-43. PubMed ID: 8419247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of the toxic effects of cachectin by concurrent insulin administration.
    Fraker DL; Merino MJ; Norton JA
    Am J Physiol; 1989 Jun; 256(6 Pt 1):E725-31. PubMed ID: 2660586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats.
    Llovera M; López-Soriano FJ; Argilés JM
    J Natl Cancer Inst; 1993 Aug; 85(16):1334-9. PubMed ID: 8340946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue.
    Kettelhut IC; Goldberg AL
    J Clin Invest; 1988 May; 81(5):1384-9. PubMed ID: 3163348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor induces skeletal muscle protein breakdown in rats.
    Goodman MN
    Am J Physiol; 1991 May; 260(5 Pt 1):E727-30. PubMed ID: 2035628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective tolerance to the toxic and metabolic effects of interleukin 1.
    Mengozzi M; Ghezzi P
    Endocrinology; 1991 Mar; 128(3):1668-72. PubMed ID: 1999179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression.
    Ulich TR; Guo KZ; Irwin B; Remick DG; Davatelis GN
    Am J Pathol; 1990 Nov; 137(5):1173-85. PubMed ID: 2240164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cachectic effects of recombinant human tumor necrosis factor in rats.
    Darling G; Fraker DL; Jensen JC; Gorschboth CM; Norton JA
    Cancer Res; 1990 Jul; 50(13):4008-13. PubMed ID: 2354450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock.
    Winter BK; Fiskum G; Gallo LL
    Br J Cancer; 1995 Nov; 72(5):1173-9. PubMed ID: 7577464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes.
    Vogel SN; Kaufman EN; Tate MD; Neta R
    Infect Immun; 1988 Oct; 56(10):2650-7. PubMed ID: 3262089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase.
    Nawabi MD; Block KP; Chakrabarti MC; Buse MG
    J Clin Invest; 1990 Jan; 85(1):256-63. PubMed ID: 2404025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.